Premium
Trends in complete heart block after transcatheter aortic valve replacement: A population based analysis
Author(s) -
AlOgaili Ahmed,
Fugar Setri,
Okoh Alexis,
Kolkailah Ahmed A.,
Al Hashemi Nawaf,
Ayoub Ali,
Russo Mark J.,
Kavinsky Clifford J.
Publication year - 2019
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.28156
Subject(s) - medicine , confidence interval , odds ratio , valve replacement , permanent pacemaker , cardiology , heart failure , population , surgery , stenosis , environmental health
Objectives To define the national rate of complete heart block (CHB) after transcatheter aortic valve replacement (TAVR) and its impact on procedural mortality, overall cost, and length of hospital stay. Background CHB leading to permanent pacemaker (PPM) implantation is one of the most common complications post TAVR. National data on the temporal trend of CHB post TAVR are lacking. Methods We queried the 2012–2014 National Inpatient Sample databases to identify all patients who underwent TAVR. Patients with preoperative pacemakers or implantable cardioverter‐defibrillators were excluded. Association between CHB and outcomes, and overall trends in rate of CHB, PPM implantation, and inpatient mortality were examined. Results Of 35,500 TAVR procedures, 3,675 (10.4%) had CHB. Overall, occurrence of CHB significantly increased from 8.4% in 2012 to 11.8% in 2014 (adjusted OR per year: 1.23; 95% confidence interval [CI]: 1.17–1.29, P trend <0.001). During the same period, PPM implantation increased from 9.5 to 13.7% (adjusted OR per year: 1.22; 95% CI: 1.16–1.28, P trend <0.001). Patients with CHB had higher odds of in‐hospital mortality when compared to patients without CHB (5.9% vs. 4.2%, adjusted OR: 1.32; 95% CI: 1.12–1.56; p = 0.001). Moreover, CHB was also associated with longer length of stay (LOS) and higher hospitalization cost. Conclusions There was a significant increase in rates of CHB and PPM implantation over the study period. Development of CHB was associated with increased in‐hospital mortality, LOS, and hospitalization cost.